CYTK
Cytokinetics Incorporated
$49.10
+$0.85(+1.76%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$5.82B
Volume
1.13M
52W Range
$29.31 - $59.39
Target Price
$75.16
EPS Estimates Overview
| Current Quarter | $-1.59 | Next Quarter | $-1.61 |
| Current Year | $-5.65 | Next Year | $-5.82 |
| QoQ Growth | -1.3% | YoY Growth | -3.0% |
| 3Y EPS CAGR | -23.4% | Target Price | $75.16 |
| Consensus | Buy | Upside | +53.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $49.10 | +1.8% | 1.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW